Sihuan Pharmaceutical Holdings Group Ltd.
Sihuan Pharmaceutical Holdings Group Ltd.
Your view on SHPHF
Overview
What the company does, where it operates, and who runs it.
About Sihuan Pharmaceutical Holdings Group Ltd.
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- CEO
- Weicheng Guo
- Headquarters
- Convention Plaza, Wan Chai, HK
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- CEO
- Weicheng Guo
- Headquarters
- Convention Plaza, Wan Chai, HK
Sihuan Pharmaceutical Holdings Group Ltd., an investment holding company, engages in the research and development, manufacture, marketing, and sale of pharmaceutical products in the People's Republic of China. It offers drugs in the oncology, metabolic diseases, digestive system, and other therapeutic areas.
The company is also involved in the investment and sale of medical beauty products; manufacture of medical instruments; investment in properties; construction for medical projects; and project preparation for pharmaceutical products manufacturing.
In addition, it provides information support, general hospital, hospital management, biotechnology promotion, and medical aesthetic research and development services. The company was founded in 2001 and is based in Wanchai, Hong Kong.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for Sihuan Pharmaceutical Holdings Group Ltd., and the rating behind it. SHPHF last traded at $0.17, 18.4× trailing earnings — the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for Sihuan Pharmaceutical Holdings Group Ltd.. Starting points for Sihuan Pharmaceutical Holdings Group Ltd.: P/E 18.4, EPS $0.03, beta 1.14 — an Drug Manufacturers - Specialty & Generic name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for Sihuan Pharmaceutical Holdings Group Ltd.. Sihuan Pharmaceutical Holdings Group Ltd. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for Sihuan Pharmaceutical Holdings Group Ltd.. Trailing twelve-month EPS for Sihuan Pharmaceutical Holdings Group Ltd. stands at $0.03. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for Sihuan Pharmaceutical Holdings Group Ltd.. Sihuan Pharmaceutical Holdings Group Ltd. has reported as a listed company since 2012. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Sihuan Pharmaceutical Holdings Group Ltd. valued side by side against its closest peers. Sihuan Pharmaceutical Holdings Group Ltd. is measured against Drug Manufacturers - Specialty & Generic peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold Sihuan Pharmaceutical Holdings Group Ltd., and how their positions are changing. At a $1.55B market value, institutional positions materially move Sihuan Pharmaceutical Holdings Group Ltd.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by Sihuan Pharmaceutical Holdings Group Ltd. executives and directors. Shares of Sihuan Pharmaceutical Holdings Group Ltd. have traded between $0.05 and $0.21 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming Sihuan Pharmaceutical Holdings Group Ltd.. Sihuan Pharmaceutical Holdings Group Ltd. is a $1.55B Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming Sihuan Pharmaceutical Holdings Group Ltd.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for Sihuan Pharmaceutical Holdings Group Ltd.. Coverage tracks Sihuan Pharmaceutical Holdings Group Ltd. within Drug Manufacturers - Specialty & Generic (Healthcare). Press releases and market coverage, newest first.